Loading...
•
Sep 30, 2020
CareDx Q3 2020 Earnings Report
Achieved revenue growth and positive Medicare coverage for AlloSure Heart.
Key Takeaways
CareDx reported a strong third quarter, achieving a 58% year-over-year revenue increase to $53.4 million. The company also saw a rise in non-GAAP net income to $5.1 million and provided over 21,800 AlloSure Kidney and AlloMap Heart patient results.
Total revenue reached $53.4 million, a 58% increase year-over-year.
Over 21,800 AlloSure Kidney and AlloMap Heart patient results were provided.
Final positive Medicare coverage decision was received for AlloSure Heart.
Pivotal AlloSure Lung data was published.
Revenue by Segment
Forward Guidance
Due to the continued uncertainties with respect to the COVID-19 pandemic, CareDx will not be providing revenue guidance at this time.
Revenue & Expenses
Visualization of income flow from segment revenue to net income
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...